Geneos Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Geneos Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-51	Closed	-$2.08K	–	2125
2023 Q3	$2.08K	Hold	51	–	–	﹤0.01%	1929
2023 Q2	$2.48K	Hold	51	–	–	﹤0.01%	1894
2023 Q1	$2.53K	Hold	51	–	–	﹤0.01%	1868
2022 Q4	$2.59K	Hold	51	–	–	﹤0.01%	1842
2022 Q3	$2K	Hold	51	–	–	﹤0.01%	1838
2022 Q2	$2K	Buy	51 +1	+2%	+$51	﹤0.01%	2386
2022 Q1	$3K	Hold	50	–	–	﹤0.01%	2460
2021 Q4	$3K	Hold	50	–	–	﹤0.01%	2521
2021 Q3	$4K	Buy	+50	New	+$4.68K	﹤0.01%	2503

Other funds holding GNOM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Geneos Wealth Management's GNOM Position: Q4 2023 in Review

Geneos Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2023, closing a stake of 51 shares — an estimated $2.08K sold.

Geneos Wealth Management first reported a position in GNOM in Q3 2021 and held it in 9 quarters. The position peaked at $4K in Q3 2021. 61 funds tracked by Wall St. Rank hold GNOM as of Q4 2023.

Geneos Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
Geneos Wealth Management sold 51 Global X Genomics & Biotechnology ETF shares in Q4 2023, an estimated $2.08K.
Geneos Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and held it in 9 quarters.
Geneos Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $4K in Q3 2021.
61 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2023.

Based on Geneos Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.